Alto Ingredients (ALTO) 10-Q8 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2022	Nov. 04, 2022
Document Information Line Items
Entity Registrant Name	ALTO INGREDIENTS, INC.
Trading Symbol	ALTO
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		73,956,108
Amendment Flag	false
Entity Central Index Key	0000778164
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-21467
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	41-2170618
Entity Address, Address Line One	1300 South Second Street
Entity Address, City or Town	Pekin
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	61554
City Area Code	(916)
Local Phone Number	403-2123
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	[1]
Current Assets:
Cash and cash equivalents	$ 28,458	$ 50,612
Restricted cash	3,955	11,513
Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively)	76,455	86,888
Inventories	61,088	54,373
Derivative instruments	7,384	15,839
Notes receivable, current		3,125
Other current assets	8,966	7,176
Total current assets	186,306	229,526
Property and equipment, net	233,475	222,550
Other Assets:
Right of use operating lease assets, net	12,895	13,413
Notes receivable, noncurrent		11,641
Intangible assets, net	9,234	2,678
Goodwill	5,970
Other assets	6,788	5,145
Total other assets	34,887	32,877
Total Assets	454,668	484,953
Current Liabilities:
Accounts payable – trade	17,493	23,251
Accrued liabilities	22,172	21,307
Current portion – operating leases	3,646	3,909
Derivative instruments	1,106	13,582
Other current liabilities	10,096	7,553
Total current liabilities	54,513	69,602
Long-term debt, net of current portion	45,888	50,361
Operating leases, net of current portion	9,201	9,382
Other liabilities	10,068	10,394
Total Liabilities	119,670	139,739
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of September 30, 2022	1	1
Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	74	73
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Additional paid-in capital	1,036,459	1,037,205
Accumulated other comprehensive loss	(284)	(284)
Accumulated deficit	(701,252)	(691,781)
Total Stockholders’ Equity	334,998	345,214
Total Liabilities and Stockholders’ Equity	$ 454,668	$ 484,953

[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	[1]
Net of allowance for doubtful accounts (in Dollars)	$ 135	$ 378
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	300,000	300,000
Common stock, shares issued	73,956	72,778
Common stock, shares outstanding	73,956	72,778
Series A Preferred Stock
Preferred stock, shares authorized	1,684	1,684
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock
Preferred stock, shares authorized	1,581	1,581
Preferred stock, shares issued	927	927
Preferred stock, shares outstanding	927	927
Preferred stock, liquidation preference (in Dollars)	$ 18,075
Non-Voting Common Stock
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	3,553	3,553
Common stock, shares issued	1	1
Common stock, shares outstanding	1	1

[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net sales	$ 336,877	$ 305,556	$ 1,007,184	$ 822,400
Cost of goods sold	356,716	308,955	1,013,406	796,729
Gross profit (loss)	(19,839)	(3,399)	(6,222)	25,671
Selling, general and administrative expenses	(7,403)	(5,533)	(24,028)	(19,777)
Asset impairments				(3,100)
Income (loss) from operations	(27,242)	(8,932)	(30,250)	2,794
Interest expense, net	(340)	(429)	(859)	(3,359)
Income from cash grant			22,652
Income from loan forgiveness		5,973		9,860
Other income (expense), net	(456)	256	(68)	641
Income (loss) before provision for income taxes	(28,038)	(3,132)	(8,525)	9,936
Provision for income taxes
Net income (loss)	(28,038)	(3,132)	(8,525)	9,936
Preferred stock dividends	(319)	(319)	(946)	(946)
Income allocated to participating securities				(120)
Net income (loss) available to common stockholders	$ (28,357)	$ (3,451)	$ (9,471)	$ 8,870
Net income (loss) per share, basic (in Dollars per share)	$ (0.39)	$ (0.05)	$ (0.13)	$ 0.12
Net income (loss) per share, diluted (in Dollars per share)	$ (0.39)	$ (0.05)	$ (0.13)	$ 0.12
Weighted-average shares outstanding, basic (in Shares)	73,011	71,383	71,815	71,002
Weighted-average shares outstanding, diluted (in Shares)	73,011	71,383	71,815	72,260

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities:
Net income (loss)	$ (8,525)	$ 9,936
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization of intangibles	19,122	17,520
Inventory valuation	7,963
Asset impairments		3,100
Income from loan forgiveness		(9,860)
Non-cash compensation	2,546	2,283
Amortization of deferred financing fees	29	732
Bad debt expense (benefit)	(187)	140
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable	16,137	(35,072)
Inventories	(13,290)	(20,192)
Other assets	(7,472)	8,011
Operating leases	(3,799)	(3,184)
Assets held-for-sale		(2,874)
Liabilities held-for-sale		1,467
Accounts payable and accrued expenses	(10,684)	8,482
Net cash provided by (used in) operating activities	1,840	(19,511)
Investing Activities:
Proceeds from principal payments on notes receivable	14,766
Proceeds from asset sales		19,500
Additions to property and equipment	(25,233)	(12,240)
Purchase of Eagle Alcohol, net of cash acquired	(14,685)
Net cash provided by (used in) investing activities	(25,152)	7,260
Financing Activities:
Net proceeds from (payments on) Kinergy’s line of credit	(4,452)	38,198
Stock repurchases	(1,002)
Proceeds from stock option exercises		462
Principal payments on borrowings		(37,810)
Preferred stock dividends paid	(946)
Net cash provided by (used in) financing activities	(6,400)	850
Net change in cash, cash equivalents and restricted cash	(29,712)	(11,401)
Cash, cash equivalents and restricted cash at beginning of period	62,125	48,187
Cash, cash equivalents and restricted cash at end of period	32,413	36,786
Reconciliation of total cash, cash equivalents and restricted cash:
Cash and cash equivalents	28,458	36,029
Restricted cash	3,955	757
Total cash, cash equivalents and restricted cash	32,413	36,786
Supplemental Information:
Interest paid	961	3,194
Accrued preferred stock dividends		$ 946

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accum. Other Comprehensive Loss	Non- Controlling Interests	Total
Balances at Dec. 31, 2020	$ 1	$ 72	$ 1,036,638	$ (736,598)	$ (3,878)		$ 296,235
Balances (in Shares) at Dec. 31, 2020	927	72,487
Restricted stock issued to employees and directors, net of cancellations and tax		$ 1	(186)				(185)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		550
Stock-based compensation			804				804
Issuances of common stock			462				462
Issuances of common stock (in Shares)		124
Preferred stock dividends				(312)			(312)
Net income (loss)				4,678			4,678
Balances at Mar. 31, 2021	$ 1	$ 73	1,037,718	(732,232)	(3,878)		301,682
Balances (in Shares) at Mar. 31, 2021	927	73,161
Balances at Dec. 31, 2020	$ 1	$ 72	1,036,638	(736,598)	(3,878)		296,235
Balances (in Shares) at Dec. 31, 2020	927	72,487
Net income (loss)							9,936
Balances at Sep. 30, 2021	$ 1	$ 73	1,036,608	(727,608)	(3,878)		305,196
Balances (in Shares) at Sep. 30, 2021	927	72,800
Balances at Mar. 31, 2021	$ 1	$ 73	1,037,718	(732,232)	(3,878)		301,682
Balances (in Shares) at Mar. 31, 2021	927	73,161
Restricted stock issued to employees and directors, net of cancellations and tax			(2,589)				(2,589)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		(350)
Stock-based compensation			851				851
Preferred stock dividends				(315)			(315)
Net income (loss)				8,390			8,390
Balances at Jun. 30, 2021	$ 1	$ 73	1,035,980	(724,157)	(3,878)		308,019
Balances (in Shares) at Jun. 30, 2021	927	72,811
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		(11)
Stock-based compensation			628				628
Preferred stock dividends				(319)			(319)
Net income (loss)				(3,132)			(3,132)
Balances at Sep. 30, 2021	$ 1	$ 73	1,036,608	(727,608)	(3,878)		305,196
Balances (in Shares) at Sep. 30, 2021	927	72,800
Balances at Dec. 31, 2021	$ 1	$ 73	1,037,205	(691,781)	(284)		345,214
Balances (in Shares) at Dec. 31, 2021	927	72,778
Restricted stock issued to employees and directors, net of cancellations and tax			(9)				(9)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		684
Stock-based compensation			673				673
Shares issued for Eagle Alcohol acquisition		$ 1					1
Shares issued for Eagle Alcohol acquisition (in Shares)		949
Preferred stock dividends				(312)			(312)
Net income (loss)				(2,602)			(2,602)
Balances at Mar. 31, 2022	$ 1	$ 74	1,037,869	(694,695)	(284)		342,965
Balances (in Shares) at Mar. 31, 2022	927	74,411
Balances at Dec. 31, 2021	$ 1	$ 73	1,037,205	(691,781)	(284)		345,214
Balances (in Shares) at Dec. 31, 2021	927	72,778
Net income (loss)							(8,525)
Balances at Sep. 30, 2022	$ 1	$ 74	1,036,459	(701,252)	(284)		334,998
Balances (in Shares) at Sep. 30, 2022	927	73,956
Balances at Mar. 31, 2022	$ 1	$ 74	1,037,869	(694,695)	(284)		342,965
Balances (in Shares) at Mar. 31, 2022	927	74,411
Restricted stock issued to employees and directors, net of cancellations and tax			(2,283)				(2,283)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		(223)
Stock-based compensation			1,106				1,106
Preferred stock dividends				(315)			(315)
Net income (loss)				22,115			22,115
Balances at Jun. 30, 2022	$ 1	$ 74	1,036,692	(672,895)	(284)		363,588
Balances (in Shares) at Jun. 30, 2022	927	74,188
Restricted stock issued to employees and directors, net of cancellations and tax			2				2
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)		27
Stock repurchases			(1,002)				(1,002)
Stock repurchases (in Shares)		(259)
Stock-based compensation			767				767
Preferred stock dividends				(319)			(319)
Net income (loss)				(28,038)			(28,038)
Balances at Sep. 30, 2022	$ 1	$ 74	$ 1,036,459	$ (701,252)	$ (284)		$ 334,998
Balances (in Shares) at Sep. 30, 2022	927	73,956

Organization and Basis of Prese

Organization and Basis of Presentation	9 Months Ended
Organization and Basis of Presentation	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	1. ORGANIZATION Organization and Business On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022. The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing. The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties. The Company focuses on four key markets: Health, Home & Beauty Food & Beverage Essential Ingredients Renewable Fuels As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility. Basis of Presentation – Interim Financial Statements Accounts Receivable and Allowance for Doubtful Accounts The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required. Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers. Financial Instruments Business Combinations Income from Cash Grant Accounting for Government Grants and Disclosure of Government Assistance Share Repurchase Program Estimates and Assumptions

Acquisition of Eagle Alcohol

Acquisition of Eagle Alcohol	9 Months Ended
Acquisition of Eagle Alcohol	Sep. 30, 2022
Acquisition of Eagle Alcohol [Abstract]
ACQUISITION OF EAGLE ALCOHOL	2. ACQUISITION OF EAGLE ALCOHOL. On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol are eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the next three years and an aggregate of $5.0 million in the Company’s common stock on the fourth and fifth year anniversaries of the closing date, subject to the satisfaction of certain conditions, including continued employment with the Company. With respect to these payments, the Company has recognized an estimated $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively, in selling, general and administrative expenses in the accompanying consolidated statements of operations. Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol purchases bulk alcohol from suppliers and then stores, denatures, packages, and resells alcohol products in smaller sizes, including tank trucks, totes, and drums, that garner a premium to bulk alcohols. Eagle Alcohol delivers products to customers in the beverage, food, and related-process industries via its own dedicated trucking fleet and common carrier. The acquisition has provided the Company further vertical integration and access to new markets in the specialty alcohol industry. Eagle Alcohol’s unaudited results for the three months ended September 30, 2022 and 2021 generated $4.2 million and $9.9 million in net sales and $0.0 million and $1.0 million in net income, respectively. Eagle Alcohol’s unaudited results for the nine months ended September 30, 2022 and 2021 generated $12.1 million and $27.5 million in net sales and $0.1 million and $3.0 million in net income, respectively. The following table presents unaudited pro forma combined financial information assuming the acquisition occurred on January 1, 2021 (dollars in thousands except per share amounts): Three Months Ended September 30, 2022 2021 Revenues – pro forma $ 336,877 $ 311,821 Net loss available to common stockholders – pro forma $ (28,357 ) $ (3,424 ) Diluted net loss per share – pro forma $ (0.38 ) $ (0.05 ) Diluted shares 73,960 72,332 Nine Months Ended 2022 2021 Revenues – pro forma $ 1,007,711 $ 840,947 Net income (loss) available to common stockholders – pro forma $ (9,538 ) $ 8,474 Diluted net income (loss) per share – pro forma $ (0.13 ) $ 0.12 Diluted shares 72,764 73,209 The following preliminary allocation of the estimated purchase price assumes, with the exception of property and equipment and intangibles, carrying values approximate fair value. Estimates of uncollectible accounts receivable are not considered material due to the short-term nature and customer collection history. The preliminary estimate of working capital is under review by management and is subject to change. Based upon these assumptions, the preliminary purchase price allocation is as follows (in thousands): Cash and equivalents $ 705 Accounts receivable 5,517 Inventories 1,388 Other assets 29 Total current assets 7,639 Property and equipment 1,067 Right of use assets 2,749 Total tangible assets $ 11,455 Current liabilities $ 6,262 Right of use liability 2,749 Total liabilities $ 9,011 Net tangible assets acquired $ 2,444 Customer relationships 6,556 Tradename 420 Goodwill 5,970 Total Purchase Price $ 15,390 Goodwill represents the value of the downstream integration that the operations of Eagle Alcohol will add to the Company. The Company expects the amortization of goodwill to be deductible for tax purposes. For the identifiable intangible assets, the Company has estimated 12 years for useful lives for customer relationships and 10 years for tradename. For the three months ended September 30, 2022, the Company recorded amortization expense of $137,000 and $10,000 for customer relationships and tradename, respectively. For the nine months ended September 30, 2022, the Company recorded amortization expense of $390,000 and $30,000 for customer relationships and tradename, respectively. Any changes to the initial estimates of the fair value of the acquired assets and assumed liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill if net assets acquired are less than the purchase price. The Company did not incur any material acquisition costs.

Segments

Segments	9 Months Ended
Segments	Sep. 30, 2022
Segment Reporting [Abstract]
SEGMENTS	3. SEGMENTS. The Company reports its financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis and third-party fuel-grade ethanol sales (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus (“Pekin Campus”), and (3) Other production, which includes the production and sale of renewable fuel and essential ingredients produced at all of the Company’s other production facilities on an aggregated basis (“Other production”), none of which are individually so significant as to be considered a reportable segment. The following tables set forth certain financial data for the Company’s operating segments (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net Sales Pekin Campus, recorded as gross: Alcohol sales $ 133,680 $ 114,587 $ 393,498 $ 341,967 Essential ingredient sales 54,537 46,016 169,670 140,670 Intersegment sales 332 293 857 919 Total Pekin Campus sales 188,549 160,896 564,025 483,556 Marketing and distribution: Alcohol sales, gross $ 55,262 $ 112,391 $ 172,746 $ 255,702 Alcohol sales, net 308 505 975 1,489 Intersegment sales 3,121 2,415 9,360 7,277 Total marketing and distribution sales 58,691 115,311 183,081 264,468 Other production, recorded as gross: Alcohol sales $ 64,492 $ 25,190 $ 191,483 $ 63,311 Essential ingredient sales 24,439 6,867 66,748 19,261 Intersegment sales 3 259 14 896 Total Other production sales 88,934 32,316 258,245 83,468 Corporate and other 4,159 — 12,064 — Intersegment eliminations (3,456 ) (2,967 ) (10,231 ) (9,092 ) Net sales as reported $ 336,877 $ 305,556 $ 1,007,184 $ 822,400 Cost of goods sold: Pekin Campus $ 207,939 $ 169,721 $ 572,512 $ 468,972 Marketing and distribution 55,159 105,902 173,670 245,606 Other production 91,663 35,613 261,514 87,055 Corporate and other 2,925 — 8,995 — Intersegment eliminations (970 ) (2,281 ) (3,285 ) (4,904 ) Cost of goods sold as reported $ 356,716 $ 308,955 $ 1,013,406 $ 796,729 Gross profit (loss): Pekin Campus $ (19,390 ) $ (8,825 ) $ (8,487 ) $ 14,584 Marketing and distribution 3,532 9,409 9,411 18,862 Other production (2,729 ) (3,297 ) (3,269 ) (3,587 ) Corporate and other 1,234 — 3,069 — Intersegment eliminations (2,486 ) (686 ) (6,946 ) (4,188 ) Gross profit (loss) as reported $ (19,839 ) $ (3,399 ) $ (6,222 ) $ 25,671 Income (loss) before provision for income taxes: Pekin Campus $ (22,664 ) $ (11,830 ) $ (6,252 ) $ 8,907 Marketing and distribution 1,622 7,517 3,444 12,929 Other production (4,958 ) (4,856 ) 1,404 (12,467 ) Corporate and other (2,038 ) 6,037 (7,121 ) 567 $ (28,038 ) $ (3,132 ) $ (8,525 ) $ 9,936 Depreciation and amortization of intangibles: Pekin Campus $ 4,758 $ 4,372 $ 14,381 $ 13,043 Other production 1,273 1,468 4,095 4,433 Corporate and other 229 11 646 44 $ 6,260 $ 5,851 $ 19,122 $ 17,520 Interest expense, net of capitalized interest: Pekin Campus $ (48 ) $ 176 $ (81 ) $ 767 Marketing and distribution 487 295 1,060 721 Other production (74 ) — (128 ) 182 Corporate and other (25 ) (42 ) 8 1,689 $ 340 $ 429 $ 859 $ 3,359 The following table sets forth the Company’s total assets by operating segment (in thousands): September 30, December 31, Total assets: Pekin Campus $ 247,449 $ 266,197 Marketing and distribution 111,900 130,302 Other production 63,904 57,046 Corporate and other 31,415 31,408 $ 454,668 $ 484,953

Inventories

Inventories	9 Months Ended
Inventories	Sep. 30, 2022
Inventory Disclosure [Abstract]
INVENTORIES	4. INVENTORIES. Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of a valuation adjustment of $7,963,000 and $0 as of September 30, 2022 and December 31, 2021, respectively. Inventory balances consisted of the following (in thousands): September 30, December 31, Finished goods $ 40,630 $ 35,509 Work in progress 8,084 6,909 Raw materials 11,321 10,837 Other 1,053 1,118 Total $ 61,088 $ 54,373

Derivatives

Derivatives	9 Months Ended
Derivatives	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES	5. DERIVATIVES. The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results. Commodity Risk – Cash Flow Hedges Commodity Risk – Non-Designated Hedges Non Designated Derivative Instruments As of September 30, 2022 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 3,955 Commodity contracts Derivative assets $ 7,384 Derivative liabilities $ 1,106 As of December 31, 2021 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 11,513 Commodity contracts Derivative assets $ 15,839 Derivative liabilities $ 13,582 The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but its intent is to close out positions individually, therefore, they are reported at gross. The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands): Realized Losses For the Three Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ (13,332 ) $ (2,894 ) $ (13,332 ) $ (2,894 ) Realized Gains Type of Instrument Statements of Operations Location For the Nine Months Ended September 30, 2022 2021 Commodity contracts Cost of goods sold $ 16,143 $ 21,449 $ 16,143 $ 21,449 Unrealized Gains For the Three Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ 11,560 $ 1,918 $ 11,560 $ 1,918 Unrealized Gains (Losses) For the Nine Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ 4,021 $ (3,014 ) $ 4,021 $ (3,014 )

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2022
Debt [Abstract]
DEBT	6. DEBT. Long-term borrowings are summarized as follows (in thousands): September 30, December 31, Kinergy line of credit $ 45,949 $ 50,401 Less unamortized debt financing costs (61 ) (40 ) Less short-term portion — — Long-term debt $ 45,888 $ 50,361 As of September 30, 2022, Kinergy had $30.7 million in unused borrowing availability under its line of credit. The Company believes it was in compliance with its covenants under the line of credit as of September 30, 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	7. COMMITMENTS AND CONTINGENCIES. Sales Commitments Purchase Commitments Litigation – General

Pension and Retirement Benefit

Pension and Retirement Benefit Plans	9 Months Ended
Pension and Retirement Benefit Plans	Sep. 30, 2022
Retirement Benefits [Abstract]
PENSION AND RETIREMENT BENEFIT PLANS	8. PENSION AND RETIREMENT BENEFIT PLANS. The Company sponsors a defined benefit pension plan (the “Retirement Plan”) and a healthcare and life insurance plan (the “Postretirement Plan”). The Retirement Plan is noncontributory, and covers only “grandfathered” unionized employees at the Company’s Pekin, Illinois facility who fulfill minimum age and service requirements. Benefits are based on a prescribed formula based upon the employee’s years of service. The Retirement Plan, which is part of a collective bargaining agreement, covers only union employees hired prior to November 1, 2010. The Company uses a December 31 measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. As of December 31, 2021, the Retirement Plan’s accumulated projected benefit obligation was $23.8 million, with a fair value of plan assets of $20.0 million. The underfunded amount of $3.8 million is recorded on the Company’s consolidated balance sheet in other liabilities. For the three months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $8,000, comprised of $273,000 of expected return on plan assets, partially offset by $164,000 in interest cost and $101,000 in service cost. For the three months ended September 30, 2021, the Retirement Plan’s net periodic expense was $22,000, comprised of $151,000 in interest cost and $109,000 in service cost, partially offset by $238,000 of expected return on plan assets. For the nine months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $24,000, comprised of $819,000 of expected return on plan assets, partially offset by $492,000 in interest cost and $303,000 in service cost. For the nine months ended September 30, 2021, the Retirement Plan’s net periodic expense was $66,000, comprised of $453,000 in interest cost and $327,000 in service cost, partially offset by $714,000 of expected return on plan assets. The Postretirement Plan provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees. Employees hired after December 31, 2000 are not eligible to participate in the Postretirement Plan. The Postretirement Plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan declines at age 65 from a defined benefit to a defined dollar cap based upon years of service. As of December 31, 2021, the Postretirement Plan’s accumulated projected benefit obligation was $4.3 million and is recorded on the Company’s consolidated balance sheet in other liabilities. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. For the three months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $32,000, comprised of $6,000 of interest cost and $26,000 of service cost. For the three months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $42,000, comprised of $10,000 of interest cost, $26,000 of service cost and $6,000 of amortization expense. For the nine months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $96,000, comprised of $18,000 of interest cost and $78,000 of service cost. For the nine months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $126,000, comprised of $30,000 of interest cost, $78,000 of service cost and $18,000 of amortization expense.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	9. FAIR VALUE MEASUREMENTS. The fair va lue hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows: ● Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities; ● Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and ● Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period. Pooled separate accounts Long-Lived Assets Held-for-Sale Other Derivative Instruments The following table summarizes recurring and nonrecurring fair value measurements by level at September 30, 2022 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets: Derivative financial instruments $ 7,384 $ 7,384 $ — $ — Liabilities: Derivative financial instruments $ (1,106 ) $ (1,106 ) $ — $ — The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2021 (in thousands): Benefit Plan Fair Percentage Value Level 1 Level 2 Level 3 Allocation Assets: Derivative financial instruments $ 15,839 $ 15,839 $ — $ — Long-lived assets held-for-sale 1,000 — — 1,000 Defined benefit plan assets (1) (pooled separate accounts): Large U.S. Equity(2) 5,612 — 5,612 — 28 % Small/Mid U.S. Equity(3) 3,684 — 3,684 — 18 % International Equity(4) 2,909 — 2,909 — 15 % Fixed Income(5) 7,782 — 7,782 — 39 % $ 36,826 $ 15,839 $ 19,987 $ 1,000 Liabilities: Derivative financial instruments $ (13,582 ) $ (13,582 ) $ — $ — (1) Included in other assets in the consolidated balance sheets. (2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
Earnings (Loss) Per Share	Sep. 30, 2022
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	10. EARNINGS (LOSS) PER SHARE. The following tables compute basic and diluted earnings (loss) per share (in thousands, except per share data): Three Months Ended September 30, 2022 Loss Shares Per-Share Net loss $ (28,038 ) Less: Preferred stock dividends (319 ) Basic and Diluted loss per share: Loss available to common stockholders $ (28,357 ) 73,011 $ (0.39 ) Three Months Ended September 30, 2021 Loss Shares Per-Share Net loss $ (3,132 ) Less: Preferred stock dividends (319 ) Basic and Diluted loss per share: Loss available to common stockholders $ (3,451 ) 71,383 $ (0.05 ) Nine Months Ended September 30, 2022 Loss Shares Per-Share Net loss $ (8,525 ) Less: Preferred stock dividends (946 ) Basic and Diluted loss per share: Loss available to common stockholders $ (9,471 ) 71,815 $ (0.13 ) Nine Months Ended September 30, 2021 Income Shares Per-Share Net income $ 9,936 Less: Preferred stock dividends (946 ) Less: Income allocated to participating securities (120 ) Basic income per share: Income available to common stockholders $ 8,870 71,002 $ 0.12 Add: Dilutive instruments — 1,258 Diluted income per share: Income available to common stockholders $ 8,870 72,260 $ 0.12 There were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the three and nine months ended September 30, 2022 and 2021. These securities were not considered in calculating diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021, as their effect would have been anti-dilutive. At December 31, 2021, the Company had outstanding unexercised warrants to purchase 8.9 million shares of its common stock at an exercise price of $9.76 per share. These warrants expired unexercised on April 28, 2022.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	11. SUBSEQUENT EVENTS. New Term Loan Facility In connection with the term loan facility, the Company will issue to the lenders an aggregate of up to 1,602,564 shares of the Company’s common stock. Kinergy Operating Line of Credit Extension

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
Accounting Policies, by Policy (Policies)	Sep. 30, 2022
Accounting Policies [Abstract]
Organization and Business	Organization and Business On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022. The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing. The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties. The Company focuses on four key markets: Health, Home & Beauty Food & Beverage Essential Ingredients Renewable Fuels As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.
Basis of Presentation–Interim Financial Statements	Basis of Presentation – Interim Financial Statements
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required. Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.
Financial Instruments	Financial Instruments
Business Combinations	Business Combinations
Income from Cash Grant	Income from Cash Grant Accounting for Government Grants and Disclosure of Government Assistance
Share Repurchase Program	Share Repurchase Program
Estimates and Assumptions	Estimates and Assumptions

Acquisition of Eagle Alcohol (T

Acquisition of Eagle Alcohol (Tables)	9 Months Ended
Acquisition of Eagle Alcohol (Tables)	Sep. 30, 2022
Acquisition of Eagle Alcohol [Abstract]
Schedule of pro forma combined financial information assuming the acquisition occurred	Three Months Ended September 30, 2022 2021 Revenues – pro forma $ 336,877 $ 311,821 Net loss available to common stockholders – pro forma $ (28,357 ) $ (3,424 ) Diluted net loss per share – pro forma $ (0.38 ) $ (0.05 ) Diluted shares 73,960 72,332 Nine Months Ended 2022 2021 Revenues – pro forma $ 1,007,711 $ 840,947 Net income (loss) available to common stockholders – pro forma $ (9,538 ) $ 8,474 Diluted net income (loss) per share – pro forma $ (0.13 ) $ 0.12 Diluted shares 72,764 73,209
Schedule of preliminary purchase price allocation	Cash and equivalents $ 705 Accounts receivable 5,517 Inventories 1,388 Other assets 29 Total current assets 7,639 Property and equipment 1,067 Right of use assets 2,749 Total tangible assets $ 11,455 Current liabilities $ 6,262 Right of use liability 2,749 Total liabilities $ 9,011 Net tangible assets acquired $ 2,444 Customer relationships 6,556 Tradename 420 Goodwill 5,970 Total Purchase Price $ 15,390

Segments (Tables)

Segments (Tables)	9 Months Ended
Segments (Tables)	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of financial data for operating segments	Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net Sales Pekin Campus, recorded as gross: Alcohol sales $ 133,680 $ 114,587 $ 393,498 $ 341,967 Essential ingredient sales 54,537 46,016 169,670 140,670 Intersegment sales 332 293 857 919 Total Pekin Campus sales 188,549 160,896 564,025 483,556 Marketing and distribution: Alcohol sales, gross $ 55,262 $ 112,391 $ 172,746 $ 255,702 Alcohol sales, net 308 505 975 1,489 Intersegment sales 3,121 2,415 9,360 7,277 Total marketing and distribution sales 58,691 115,311 183,081 264,468 Other production, recorded as gross: Alcohol sales $ 64,492 $ 25,190 $ 191,483 $ 63,311 Essential ingredient sales 24,439 6,867 66,748 19,261 Intersegment sales 3 259 14 896 Total Other production sales 88,934 32,316 258,245 83,468 Corporate and other 4,159 — 12,064 — Intersegment eliminations (3,456 ) (2,967 ) (10,231 ) (9,092 ) Net sales as reported $ 336,877 $ 305,556 $ 1,007,184 $ 822,400 Cost of goods sold: Pekin Campus $ 207,939 $ 169,721 $ 572,512 $ 468,972 Marketing and distribution 55,159 105,902 173,670 245,606 Other production 91,663 35,613 261,514 87,055 Corporate and other 2,925 — 8,995 — Intersegment eliminations (970 ) (2,281 ) (3,285 ) (4,904 ) Cost of goods sold as reported $ 356,716 $ 308,955 $ 1,013,406 $ 796,729 Gross profit (loss): Pekin Campus $ (19,390 ) $ (8,825 ) $ (8,487 ) $ 14,584 Marketing and distribution 3,532 9,409 9,411 18,862 Other production (2,729 ) (3,297 ) (3,269 ) (3,587 ) Corporate and other 1,234 — 3,069 — Intersegment eliminations (2,486 ) (686 ) (6,946 ) (4,188 ) Gross profit (loss) as reported $ (19,839 ) $ (3,399 ) $ (6,222 ) $ 25,671 Income (loss) before provision for income taxes: Pekin Campus $ (22,664 ) $ (11,830 ) $ (6,252 ) $ 8,907 Marketing and distribution 1,622 7,517 3,444 12,929 Other production (4,958 ) (4,856 ) 1,404 (12,467 ) Corporate and other (2,038 ) 6,037 (7,121 ) 567 $ (28,038 ) $ (3,132 ) $ (8,525 ) $ 9,936 Depreciation and amortization of intangibles: Pekin Campus $ 4,758 $ 4,372 $ 14,381 $ 13,043 Other production 1,273 1,468 4,095 4,433 Corporate and other 229 11 646 44 $ 6,260 $ 5,851 $ 19,122 $ 17,520 Interest expense, net of capitalized interest: Pekin Campus $ (48 ) $ 176 $ (81 ) $ 767 Marketing and distribution 487 295 1,060 721 Other production (74 ) — (128 ) 182 Corporate and other (25 ) (42 ) 8 1,689 $ 340 $ 429 $ 859 $ 3,359
Schedule of assets by operating segments	September 30, December 31, Total assets: Pekin Campus $ 247,449 $ 266,197 Marketing and distribution 111,900 130,302 Other production 63,904 57,046 Corporate and other 31,415 31,408 $ 454,668 $ 484,953

Inventories (Tables)

Inventories (Tables)	9 Months Ended
Inventories (Tables)	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventories	September 30, December 31, Finished goods $ 40,630 $ 35,509 Work in progress 8,084 6,909 Raw materials 11,321 10,837 Other 1,053 1,118 Total $ 61,088 $ 54,373

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
Derivatives (Tables)	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of derivatives not designated as hedging instruments	As of September 30, 2022 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 3,955 Commodity contracts Derivative assets $ 7,384 Derivative liabilities $ 1,106 As of December 31, 2021 Assets Liabilities Type of Instrument Balance Sheet Location Fair Value Balance Sheet Location Fair Value Cash collateral balance Restricted cash $ 11,513 Commodity contracts Derivative assets $ 15,839 Derivative liabilities $ 13,582
Schedule of recognized gains for its derivatives	Realized Losses For the Three Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ (13,332 ) $ (2,894 ) $ (13,332 ) $ (2,894 ) Realized Gains Type of Instrument Statements of Operations Location For the Nine Months Ended September 30, 2022 2021 Commodity contracts Cost of goods sold $ 16,143 $ 21,449 $ 16,143 $ 21,449 Unrealized Gains For the Three Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ 11,560 $ 1,918 $ 11,560 $ 1,918 Unrealized Gains (Losses) For the Nine Months Type of Instrument Statements of Operations Location 2022 2021 Commodity contracts Cost of goods sold $ 4,021 $ (3,014 ) $ 4,021 $ (3,014 )

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2022
Debt [Abstract]
Schedule of long-term borrowings	6. DEBT. September 30, December 31, Kinergy line of credit $ 45,949 $ 50,401 Less unamortized debt financing costs (61 ) (40 ) Less short-term portion — — Long-term debt $ 45,888 $ 50,361

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of recurring and nonrecurring fair value measurements	Fair Value Level 1 Level 2 Level 3 Assets: Derivative financial instruments $ 7,384 $ 7,384 $ — $ — Liabilities: Derivative financial instruments $ (1,106 ) $ (1,106 ) $ — $ — Benefit Plan Fair Percentage Value Level 1 Level 2 Level 3 Allocation Assets: Derivative financial instruments $ 15,839 $ 15,839 $ — $ — Long-lived assets held-for-sale 1,000 — — 1,000 Defined benefit plan assets (1) (pooled separate accounts): Large U.S. Equity(2) 5,612 — 5,612 — 28 % Small/Mid U.S. Equity(3) 3,684 — 3,684 — 18 % International Equity(4) 2,909 — 2,909 — 15 % Fixed Income(5) 7,782 — 7,782 — 39 % $ 36,826 $ 15,839 $ 19,987 $ 1,000 Liabilities: Derivative financial instruments $ (13,582 ) $ (13,582 ) $ — $ — (1) Included in other assets in the consolidated balance sheets. (2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. (5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
Earnings (Loss) Per Share (Tables)	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of compute basic and diluted earnings per share	Three Months Ended September 30, 2022 Loss Shares Per-Share Net loss $ (28,038 ) Less: Preferred stock dividends (319 ) Basic and Diluted loss per share: Loss available to common stockholders $ (28,357 ) 73,011 $ (0.39 ) Three Months Ended September 30, 2021 Loss Shares Per-Share Net loss $ (3,132 ) Less: Preferred stock dividends (319 ) Basic and Diluted loss per share: Loss available to common stockholders $ (3,451 ) 71,383 $ (0.05 ) Nine Months Ended September 30, 2022 Loss Shares Per-Share Net loss $ (8,525 ) Less: Preferred stock dividends (946 ) Basic and Diluted loss per share: Loss available to common stockholders $ (9,471 ) 71,815 $ (0.13 ) Nine Months Ended September 30, 2021 Income Shares Per-Share Net income $ 9,936 Less: Preferred stock dividends (946 ) Less: Income allocated to participating securities (120 ) Basic income per share: Income available to common stockholders $ 8,870 71,002 $ 0.12 Add: Dilutive instruments — 1,258 Diluted income per share: Income available to common stockholders $ 8,870 72,260 $ 0.12

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
Organization and Basis of Presentation (Details) - USD ($)	Sep. 12, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jan. 14, 2022
Organization and Basis of Presentation (Details) [Line Items]
Production capacity per year				$ 350,000,000
Annual payments of essential ingredients		$ 1,500,000		1,500,000
Accounts receivable				54,972,000		$ 63,929,000
Allowance for doubtful accounts		135,000		135,000		$ 378,000
Bad Debt Expense		253,000	$ 3,000	187,000	$ 140,000
Cash		22,652,000		22,652,000
Loan				700,000,000
Repurchase of common stock	$ 50,000,000
Excess amount of initial purchase	10,000,000
Purchase additional amount	$ 10,000,000
Repurchased an aggregate shares in cash		$ 259,000		$ 1,002,000
Ownership [Member]
Organization and Basis of Presentation (Details) [Line Items]
Equity interest owned							100%

Acquisition of Eagle Alcohol (D

Acquisition of Eagle Alcohol (Details) - USD ($)		3 Months Ended		9 Months Ended
Acquisition of Eagle Alcohol (Details) - USD ($)	Jan. 14, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Acquisition of Eagle Alcohol (Details) [Line Items]
Purchased membership interests	100%
Purchase price	$ 14,000,000
Net working capital	1,300,000
Contingent consideration	14,000,000
Combination cash	9,000,000
Aggregate of common stock	$ 5,000,000
General and administrative expenses		$ 900,000		$ 2,600,000
Net sales		4,200,000	$ 9,900,000	12,100,000	$ 27,500,000
Net income		0	1,000,000	$ 100,000	3,000,000
Estimated for useful life				12 years
Amortization amount		$ 137,000	$ 10,000	$ 390,000	$ 30,000
Customer Relationships [Member]
Acquisition of Eagle Alcohol (Details) [Line Items]
Estimated for useful life				10 years

Acquisition of Eagle Alcohol _2

Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Pro Forma Combined Financial Information Assuming The Acquisition Occurred Abstract
Revenues – pro forma	$ 336,877	$ 311,821	$ 1,007,711	$ 840,947
Net income (loss) available to common stockholders – pro forma	$ (28,357)	$ (3,424)	$ (9,538)	$ 8,474
Diluted net income (loss) per share – pro forma (in Dollars per share)	$ (0.38)	$ (0.05)	$ (0.13)	$ 0.12
Diluted shares (in Shares)	73,960	72,332	72,764	73,209

Acquisition of Eagle Alcohol _3

Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation - Acquisition of Eagle Alcohol [Member] $ in Thousands	Sep. 30, 2022 USD ($)
Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation [Line Items]
Cash and equivalents	$ 705
Accounts receivable	5,517
Inventories	1,388
Other assets	29
Total current assets	7,639
Property and equipment	1,067
Right of use assets	2,749
Total tangible assets	11,455
Current liabilities	6,262
Right of use liability	2,749
Total liabilities	9,011
Net tangible assets acquired	2,444
Customer relationships	6,556
Tradename	420
Goodwill	5,970
Total Purchase Price	$ 15,390

Segments (Details) - Schedule o

Segments (Details) - Schedule of financial data for operating segments - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Cost of goods sold:
Cost of goods sold	$ 356,716	$ 308,955	$ 1,013,406	$ 796,729
Gross profit (loss):
Gross profit	(19,839)	(3,399)	(6,222)	25,671
Pekin Campus Production [Member]
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	(48)	176	(81)	767
Marketing and Distribution [Member]
Cost of goods sold:
Cost of goods sold	55,159	105,902	173,670	245,606
Gross profit (loss):
Gross profit	3,532	9,409	9,411	18,862
Income (loss) before provision for income taxes:
Income before provision for income taxes	1,622	7,517	3,444	12,929
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	487	295	1,060	721
Other production [Member]
Cost of goods sold:
Cost of goods sold	91,663	35,613	261,514	87,055
Gross profit (loss):
Gross profit	(2,729)	(3,297)	(3,269)	(3,587)
Income (loss) before provision for income taxes:
Income before provision for income taxes	(4,958)	(4,856)	1,404	(12,467)
Depreciation and amortization of intangibles:
Depreciation and amortization of intangibles	1,273	1,468	4,095	4,433
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	(74)		(128)	182
Corporate and other [Member]
Pekin Campus, recorded as gross:
Net sales	4,159		12,064
Gross profit (loss):
Gross profit	1,234		3,069
Income (loss) before provision for income taxes:
Income before provision for income taxes	(2,038)	6,037	(7,121)	567
Depreciation and amortization of intangibles:
Depreciation and amortization of intangibles	229	11	646	44
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	(25)	(42)	8	1,689
Intersegment Eliminations [Member]
Pekin Campus, recorded as gross:
Net sales	(3,456)	(2,967)	(10,231)	(9,092)
Cost of goods sold:
Cost of goods sold	(970)	(2,281)	(3,285)	(4,904)
Gross profit (loss):
Gross profit	(2,486)	(686)	(6,946)	(4,188)
Pekin Campus Production [Member]
Cost of goods sold:
Cost of goods sold	207,939	169,721	572,512	468,972
Gross profit (loss):
Gross profit	(19,390)	(8,825)	(8,487)	14,584
Income (loss) before provision for income taxes:
Income before provision for income taxes	(22,664)	(11,830)	(6,252)	8,907
Depreciation and amortization of intangibles:
Depreciation and amortization of intangibles	4,758	4,372	14,381	13,043
Corporate and other [Member]
Cost of goods sold:
Cost of goods sold	2,925		8,995
Income (loss) before provision for income taxes [Member]
Income (loss) before provision for income taxes:
Income before provision for income taxes	(28,038)	(3,132)	(8,525)	9,936
Depreciation and amortization of intangibles [Member]
Depreciation and amortization of intangibles:
Depreciation and amortization of intangibles	6,260	5,851	19,122	17,520
Total [Member]
Interest expense, net of capitalized interest:
Interest expense, net of capitalized interest	340	429	859	3,359
Alcohol sales [Member] \| Pekin Campus Production [Member]
Pekin Campus, recorded as gross:
Net sales	133,680	114,587	393,498	341,967
Alcohol sales [Member] \| Other production [Member]
Pekin Campus, recorded as gross:
Net sales	64,492	25,190	191,483	63,311
Essential Ingredient Sales [Member] \| Pekin Campus Production [Member]
Pekin Campus, recorded as gross:
Net sales	54,537	46,016	169,670	140,670
Essential Ingredient Sales [Member] \| Other production [Member]
Pekin Campus, recorded as gross:
Net sales	24,439	6,867	66,748	19,261
Intersegment Sales [Member] \| Pekin Campus Production [Member]
Pekin Campus, recorded as gross:
Net sales	332	293	857	919
Intersegment Sales [Member] \| Marketing and Distribution [Member]
Pekin Campus, recorded as gross:
Net sales	3,121	2,415	9,360	7,277
Intersegment Sales [Member] \| Other production [Member]
Pekin Campus, recorded as gross:
Net sales	3	259	14	896
Total Pekin Campus Sales [Member] \| Pekin Campus Production [Member]
Pekin Campus, recorded as gross:
Net sales	188,549	160,896	564,025	483,556
Alcohol sales, gross [Member] \| Marketing and Distribution [Member]
Pekin Campus, recorded as gross:
Net sales	55,262	112,391	172,746	255,702
Alcohol sales, net [Member] \| Marketing and Distribution [Member]
Pekin Campus, recorded as gross:
Net sales	308	505	975	1,489
Total Marketing and Distribution Sales [Member] \| Marketing and Distribution [Member]
Pekin Campus, recorded as gross:
Net sales	58,691	115,311	183,081	264,468
Total Other production Sales [Member] \| Other production [Member]
Pekin Campus, recorded as gross:
Net sales	88,934	32,316	258,245	83,468
Net sales as reported [Member]
Pekin Campus, recorded as gross:
Net sales	$ 336,877	$ 305,556	$ 1,007,184	$ 822,400

Segments (Details) - Schedule_2

Segments (Details) - Schedule of assets by operating segments - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Total assets:
Total assets	$ 454,668	$ 484,953	[1]
Pekin Campus [Member]
Total assets:
Total assets	247,449	266,197
Marketing and distribution [Member]
Total assets:
Total assets	111,900	130,302
Other production [Member]
Total assets:
Total assets	63,904	57,046
Corporate and other [Member]
Total assets:
Total assets	$ 31,415	$ 31,408

[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.

Inventories (Details)

Inventories (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventory net	$ 7,963,000	$ 0

Inventories (Details) - Schedul

Inventories (Details) - Schedule of inventories - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Schedule Of Inventories Abstract
Finished goods	$ 40,630	$ 35,509
Work in progress	8,084	6,909
Raw materials	11,321	10,837
Other	1,053	1,118
Total	$ 61,088	$ 54,373

Derivatives (Details)

Derivatives (Details) - USD ($)	3 Months Ended		9 Months Ended
Derivatives (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Recognized net gains	$ 1,772,000	$ 976,000	$ 20,164,000	$ 18,435,000

Derivatives (Details) - Schedul

Derivatives (Details) - Schedule of derivatives not designated as hedging instruments - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule Of Derivatives Not Designated As Hedging Instruments Abstract
Type of Instrument Cash collateral balance	Cash collateral balance	Cash collateral balance
Assets, Balance Sheet Location Cash collateral balance	Restricted cash	Restricted cash
Assets, Fair Value Cash collateral balance	$ 3,955	$ 11,513
Liabilities, Balance Sheet Location Cash collateral balance
Liabilities, Fair Value Cash collateral balance
Type of Instrument Commodity contracts	Commodity contracts	Commodity contracts
Assets, Balance Sheet Location Commodity contracts	Derivative assets	Derivative assets
Assets, Fair Value Commodity contracts	$ 7,384	$ 15,839
Liabilities, Balance Sheet Location Commodity contracts	Derivative liabilities	Derivative liabilities
Liabilities, Fair Value Commodity contracts	$ 1,106	$ 13,582

Derivatives (Details) - Sched_2

Derivatives (Details) - Schedule of recognized gains for its derivatives - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Realized Losses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument	Commodity contracts
Statements of Operations Location	Cost of goods sold
Realized Gains	$ (13,332)	$ (2,894)
Total Realized Gains	$ (13,332)	(2,894)
Realized Gains [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument			Commodity contracts
Statements of Operations Location			Cost of goods sold
Realized Gains			$ 16,143	$ 21,449
Total Realized Gains			$ 16,143	21,449
Unrealized Gains [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument	Commodity contracts
Statements of Operations Location	Cost of goods sold
Unrealized Gains (Losses)	$ 11,560	1,918
Total Unrealized Gains (Losses)	$ 11,560	$ 1,918
Unrealized Gains (Losses) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Type of Instrument			Commodity contracts
Statements of Operations Location			Cost of goods sold
Unrealized Gains (Losses)			$ 4,021	(3,014)
Total Unrealized Gains (Losses)			$ 4,021	$ (3,014)

Debt (Details)

Debt (Details) $ in Millions	Sep. 30, 2022 USD ($)
Debt [Abstract]
Unused borrowing	$ 30.7

Debt (Details) - Schedule of lo

Debt (Details) - Schedule of long-term borrowings - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule Of Long Term Borrowings Abstract
Kinergy line of credit	$ 45,949	$ 50,401
Less unamortized debt financing costs	(61)	(40)
Less short-term portion
Long-term debt	$ 45,888	$ 50,361

Commitments and Contingencies (

Commitments and Contingencies (Details)	9 Months Ended
Commitments and Contingencies (Details)	Sep. 30, 2022 USD ($)
Commitments and Contingencies (Details) [Line Items]
Indexed price purchase contracts gallons	92,771,000
Open fixed-price sales contracts valued	$ 17,274,000
Future commitments for capital projects	$ 46,796,000
Alcohol from Suppliers [Member] \| Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Indexed price purchase contracts gallons	13,988,000
Fixed-price purchase contracts value	$ 45,599,000
Corn from Suppliers [Member] \| Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Fixed-price purchase contracts value	$ 38,769,000
Natural Gas [Member] \| Purchase Commitments [Member]
Commitments and Contingencies (Details) [Line Items]
Indexed price purchase contracts gallons	4,463,000
Fixed-price purchase contracts value	$ 1,947,000
Alcohol Sales Contracts [Member]
Commitments and Contingencies (Details) [Line Items]
Open fixed-price sales contracts valued	$ 101,427,000

Pension and Retirement Benefi_2

Pension and Retirement Benefit Plans (Details) - USD ($)	3 Months Ended		9 Months Ended
Pension and Retirement Benefit Plans (Details) - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Retirement Plan [Member]
Pension and Retirement Benefit Plans (Details) [Line Items]
Projected benefit obligation, amount					$ 23,800,000
Fair value of plan assets					20,000,000
Underfunded amount					3,800,000
Retirement plan’s net periodic benefit	$ 8,000
Expected return on plan assets	273,000	$ 238,000	$ 819,000	$ 714,000
Interest cost	164,000	151,000	492,000	453,000
Service cost	101,000	109,000	303,000	327,000
Net periodic expense (income)		(22,000)	24,000	66,000
Postretirement Plan [Member]
Pension and Retirement Benefit Plans (Details) [Line Items]
Projected benefit obligation, amount					$ 4,300,000
Interest cost	26,000	10,000	78,000	30,000
Service cost	6,000	26,000	18,000	78,000
Net periodic expense (income)	$ 32,000	42,000	$ 96,000	126,000
Amortization expense		$ 6,000		$ 18,000

Fair Value Measurements (Detail

Fair Value Measurements (Details)	Dec. 31, 2021 USD ($)
Fair Value Disclosures [Abstract]
Property and equipment held-for-sale	$ 1,000,000

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Assets:
Assets			$ 36,826
Derivative Financial Instruments, Assets [Member]
Assets:
Assets		$ 7,384	15,839
Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities		(1,106)	(13,582)
Long-lived assets held-for-sale [Member]
Assets:
Assets			1,000
Large U.S. Equity [Member]
Assets:
Assets	[1],[2]		$ 5,612
Benefit Plan Percentage Allocation	[1],[2]		28%
Small/Mid U.S. Equity [Member]
Assets:
Assets	[1],[3]		$ 3,684
Benefit Plan Percentage Allocation	[1],[3]		18%
International Equity [Member]
Assets:
Assets	[1],[4]		$ 2,909
Benefit Plan Percentage Allocation	[1],[4]		15%
Fixed Income [Member]
Assets:
Assets	[1],[5]		$ 7,782
Benefit Plan Percentage Allocation	[1],[5]		39%
Level 1 [Member]
Assets:
Assets			$ 15,839
Level 1 [Member] \| Derivative Financial Instruments, Assets [Member]
Assets:
Assets		7,384	15,839
Level 1 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities		(1,106)	(13,582)
Level 1 [Member] \| Long-lived assets held-for-sale [Member]
Assets:
Assets
Level 1 [Member] \| Large U.S. Equity [Member]
Assets:
Assets	[1],[2]
Level 1 [Member] \| Small/Mid U.S. Equity [Member]
Assets:
Assets	[1],[3]
Level 1 [Member] \| International Equity [Member]
Assets:
Assets	[1],[4]
Level 1 [Member] \| Fixed Income [Member]
Assets:
Assets	[1],[5]
Level 2 [Member]
Assets:
Assets			19,987
Level 2 [Member] \| Derivative Financial Instruments, Assets [Member]
Assets:
Assets
Level 2 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities
Level 2 [Member] \| Long-lived assets held-for-sale [Member]
Assets:
Assets
Level 2 [Member] \| Large U.S. Equity [Member]
Assets:
Assets	[1],[2]		5,612
Level 2 [Member] \| Small/Mid U.S. Equity [Member]
Assets:
Assets	[1],[3]		3,684
Level 2 [Member] \| International Equity [Member]
Assets:
Assets	[1],[4]		2,909
Level 2 [Member] \| Fixed Income [Member]
Assets:
Assets	[1],[5]		7,782
Level 3 [Member]
Assets:
Assets			1,000
Level 3 [Member] \| Derivative Financial Instruments, Assets [Member]
Assets:
Assets
Level 3 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Liabilities
Level 3 [Member] \| Long-lived assets held-for-sale [Member]
Assets:
Assets			1,000
Level 3 [Member] \| Large U.S. Equity [Member]
Assets:
Assets	[1],[2]
Level 3 [Member] \| Small/Mid U.S. Equity [Member]
Assets:
Assets	[1],[3]
Level 3 [Member] \| International Equity [Member]
Assets:
Assets	[1],[4]
Level 3 [Member] \| Fixed Income [Member]
Assets:
Assets	[1],[5]

[1]Included in other assets in the consolidated balance sheets.[2]This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[3]This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[4]This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.[5]This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - $ / shares	1 Months Ended	3 Months Ended		9 Months Ended
Earnings (Loss) Per Share (Details) - $ / shares	Dec. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Potentially dilutive shares from convertible securities outstanding		964,000	964,000	964,000	964,000
Outstanding unexercised warrants to purchase	8,900,000
Common stock exercise price per share (in Dollars per share)	$ 9.76
Warrants expired	Apr. 28, 2022

Earnings (Loss) Per Share (Det

Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Compute Basic And Diluted Earnings Per Share Abstract
Net income (loss)	$ (28,038)	$ (3,132)	$ (8,525)	$ 9,936
Less: Preferred stock dividends	(319)	(319)	(946)	(946)
Less: Income allocated to participating securities				(120)
Basic and Diluted loss per share:
Income (loss) available to common stockholders	$ (28,357)	$ (3,451)	$ (9,471)	$ 8,870
Income (loss) available to common stockholders (in Shares)	73,011	71,383	71,815	71,002
Income (loss) available to common stockholders (in Dollars per share)	$ (0.39)	$ (0.05)	$ (0.13)	$ 0.12
Add: Dilutive instruments
Add: Dilutive instruments (in Shares)				1,258
Diluted income per share:
Diluted Income available to common stockholders				$ 8,870
Diluted Income available to common stockholders (in Shares)				72,260
Diluted Income available to common stockholders (in Dollars per share)				$ 0.12

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]	Nov. 07, 2022 shares
Subsequent Events (Details) [Line Items]
Description of subsequent events	On November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets.
Aggregate shares of common stock	1,602,564